SMURF2 and neoplasm: PIAS3 reduction in breast tumor promotes the PIAS3 and Smurf2 pathway in tumor progression and metastasis; PIAS3-Smurf2 SUMOylation mechanism still requires more investigation in breast tumor metastasis (46).